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Abstract
I In nt tr ro od du uc ct ti io on n: :   The main purpose of this study was differentiation of bone marrow
stem cells (BMSCs) into Schwann-like cells and to determine the intensity of
apoptosis in BMSCs during the differentiation process.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Bone marrow stem cells were isolated from the femur
of adult rats and the identity of the undifferentiated BMSCs was confirmed by
the detection of specific cell surface markers. The BMSCs were differentiated
by sequential administration of β-mercaptoethanol and all-trans-retinoic acid
as pre-inducer factors and a mixture of forskolin, basic fibroblast growth factor,
platelet-derived growth factor-AA and heregulin-b1 as inducer factors. The
immunocytochemical properties of differentiated Schwann-like cells were
examined at a specified time point. Reverse transcription-polymerase chain
reaction  (RT-PCR)  was  used  to  investigate  the  gene  expression  of  the
undifferentiated and differentiated BMSCs. Cell apoptosis and viability were
assessed  with  annexin  V  and  propidium  iodide  double  staining  and
dimethylthiazol-2-yl-2, 5-diphenyltetrazolium bromide (MTT) assay.
R Re es su ul lt ts s: :   Immunocytochemistry staining and RT-PCR analysis revealed that the
induced BMSCs exhibited Schwann cell-specific markers such as S-100, P75 and
glial fibrillary acidic protein (GFAP) at the 14th day of differentiation. MTT assay
and flow cytometry revealed that of the total BMSCs in the differentiation
medium, 40% to 50% of the cells died by apoptosis, but the remaining cell
population remained strongly attached to the substrate and differentiated.
C Co on nc cl lu us si io on ns s: :   These findings indicated that BMSCs could differentiate into
Schwann-like cells. As a side effect of differentiation an increased cell death
rate was noted and our findings indicate that the principle mode of cell death
is by apoptosis.
K Ke ey y   w wo or rd ds s: :   bone marrow, stem cells, apoptosis, Schwann cells.
Introduction
The transplantation of cultured Schwann cells (SCs) into bio-engineered
conduits has been shown to improve nerve regeneration [1]. The ideal
“transplantable cell” should be easily accessible, capable of rapid expansion
in culture, immunologically inert, and capable of long-term survival 
and integration in the host tissue [2]. An alternative candidate may be
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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bone  marrow  stem  cells  (BMSCs)  [3].  Recent
transplantation  studies  have  suggested  that
transplantation of undifferentiated BMSCs in rats
showed therapeutic benefit after traumatic brain
injury [4, 5] or spinal cord injury [6]. However, in
these post-injury transplantation studies, generally
less  than  20%  of  transplanted  cells  were
immunoreactive  for  specific  antigens  [7].  In
a different paradigm, in vitro differentiation of
BMSCs into cells expressing Schwann cell antigens,
followed by in vivo transplantation, was shown to
have a regenerative effect on damaged sciatic 
nerve  [8].  This  finding  suggests  that  in  vitro
differentiation of BMSCs into cells of central and
peripheral nervous systems, followed by in vivo
transplantation, may be a potential therapy for
nervous system repair. For cell-based regenerative
therapies  BMSCs  are  expanded  in  vitro and
differentiated toward Schwann-like cells by applying
culture media contain β-mercaptoethanol (BME),
all-trans-retinoic acid (RA), forskolin, basic fibroblast
growth factor, platelet-derived growth factor-AA and
heregulin-b1  [9-11].  However,  in  these  in  vitro
studies, generally less than 50% of BMSCs were
differentiated into Schwann-like cells [11]. 
Beta-mercaptoethanol [12] and RA [13] are toxic
chemicals that were used as pre-inducer factors.
Evidence has been presented suggesting that 
RA  is  more  active  in  inhibiting  proliferation 
and inducing differentiation in relatively undif  -
ferentiated  systems,  i.e.,  neuroblastoma  and
embryonal stem cells [14]. In contrast, in other
systems, such as keratinocytes [15] and embryonal
lung cells [16], proliferation is stimulated. Moreover,
at specific concentrations in culture medium, BME
increase BMSCs apoptosis [13]. While the use of
specific chemical compounds to induce neurogenic
differentiation of BMSCs in culture has been well
documented, the potential effects on cell death
have not been elucidated [11, 13].
The  main  purpose  of  this  study  was
differentiation of BMSCs into Schwann-like cells
and to determine the intensity of apoptosis in
BMSCs during the differentiation process.
Material and methods
I Is so ol la at ti io on n   a an nd d   c cu ul lt tu ur re e   o of f   b bo on ne e   m ma ar rr ro ow w   s st te em m   c ce el ll ls s
About 6- to 8-week-old male Wistar rats of the
Albino strain were killed using diethyl ether and the
bones were collected under sterile conditions; then
all the bones were cut at both ends. The bone
marrow from each bone was collected by flushing
the bone with α Minimum Essential Medium Eagle
(αMEM)  (Sigma,  USA)  containing  1000  U/ml
Penicillin G (Sigma, USA). After filtering, the cells were
centrifuged at 1000 × g for 5 min. The purified cells
were finally dispersed in αMEM with 15% fetal bovine
serum (Sigma, USA) containing 100 U/ml penicillin
and 100 µg/ml streptomycin (Sigma, USA) [17].
C Ce el ll l   c cu ul lt tu ur re e   a an nd d   e ex xp pa an ns si io on n
The isolated BMSCs were plated in T75 tissue
culture flasks containing appropriate stem cell
medium (Sigma, USA) at a density of 10 × 105 cells
per flask. The flasks were maintained in a tissue
culture incubator at 37°C and 5% carbon dioxide.
The  medium  was  replaced  every  third  day
afterwards.  Cell  viability  was  confirmed  by
continued  cell  division  and  the  cells  were
subcultured using 3 ml of trypsin/EDTA (Sigma,
USA) when the flasks reached 90% confluence [17].
P Pr ri im ma ar ry y   c cu ul lt tu ur re e   o of f   S Sc ch hw wa an nn n   c ce el ll ls s
Primary  Schwann  cells  were  obtained  by
methods similar to those first described by Brockes
et al. [18].
F Fl lo ow w   c cy yt to om me et tr ry y
Rat BMSCs within 3-5 passages after the initial
plating of the primary culture were harvested by
trypsinization, and then the cells were fixed in
neutralized 2% paraformaldehyde solution (Sigma,
USA) for 30 min. The fixed cells were washed twice
with phosphate buffer saline (PBS) (Sigma, USA)
and incubated with antibodies to the following
antigens: CD31, CD45, CD90 and CD44 (all from
Chemicon, CA) for 30 min. Primary antibodies were
directly conjugated with FITC. Flow cytometry was
performed with a FACScan flow cytometer (Becton
Dickinson, CA) [19].
B BM MS SC Cs s   m mu ul lt ti il li in ne ea ag ge e   d di if ff fe er re en nt ti ia at ti io on n   p po ot te en nt ti ia al l
The adipogenic and osteogenic differentiation
capacity of BMSCs was confirmed according to the
previously published protocols [11].
D Di if ff fe er re en nt ti ia at ti io on n   o of f   B BM MS SC Cs s   t to o   S SC C- -l li ik ke e   c ce el ll ls s
After  subculturing  at  the  concentration  of 
10 × 105 cells/cm2, BMSCs were incubated in αMEM
containing 1 mM BME without serum for 24 h. The
culture medium was then replaced with αMEM
containing 10% FBS and 35 ng/ml RA (Sigma, USA).
Three days later, cells were finally transferred to
inducer medium containing αMEM, 10% FBS and
trophic factors of 5 µM FSK (Calbiochem, CA), 
10 ng/ml bFGF (Peprotech, UK), 5 ng/ml PDGF
(Peprotech, UK), and 200 ng/ml HRG (R&D systems,
USA) and cultured for 10 days [9].
I Im mm mu un no os st ta ai in ni in ng g   o of f   c cu ul lt tu ur re ed d   c ce el ll ls s
Differentiated BMSCs cultured on chamber slides
(Lab-Tek,  Denmark)  were  fixed  in  4%  (w/v)Arch Med Sci 1, February / 2011 47
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paraformaldehyde at 4°C for 20 min. Cell nuclei
were labelled with 6 diamidino-2-phenylindole
dihydrochloride (DAPI, Sigma-Aldrich) (1 µg/ml) for
60 min at room temperature. Cells were then
incubated overnight at 4°C with primary antibodies
to S100 (rabbit polyclonal; 1 : 200; Dako, Denmark).
The following day, slides were incubated for 2 hour
with fluorescein isothiocyanate (FITC)-conjugated
secondary antibody (horse anti-mouse or goat anti-
rabbit; 1 : 100; Vector Labs., USA). Slides were
examined  under  a fluorescence  microscope
(Olympus BX60). Cultures of Schwann cells were
similarly stained as positive controls according to
the antibodies used [11].
R RN NA A    e ex xt tr ra ac ct ti io on n    a an nd d    r re ev ve er rs se e    t tr ra an ns sc cr ri ip pt ti io on n
p po ol ly ym me er ra as se e   c ch ha ai in n   r re ea ac ct ti io on n   ( (R RT T- -P PC CR R) )   a an na al ly ys si is s   o of f
g ge en ne e   e ex xp pr re es ss si io on n
After the pre-induction and the induction periods,
the total RNA was extracted from the induced
BMSCs, the non-induced cells and Schwann cells
using RNX plus (CinnaGen) and was stored at –70°C.
The cDNA synthesis was carried out from 5 µg total
RNA using Fermentas kit (Fermentas) according to
the manufacturer's instructions. The cDNA was
amplified (the primers of the genes in this study are
listed in Table I). The 25 µl PCR product contained
the following components: 0.2 pM of each primer,
0.3 mMdNTP, 1.5 mM MgCl2, 1 Utaq DNA poly  -
merase and 1 × PCR buffer (Fermentas). The PCR
reactions  were  conducted  in  a programmable
thermocycler (Bio-Rad) with the following tem  -
perature profile: 94°C for 5 min, 35 cycles at 94°C
for 45 s, 55°C for 45 s and 72°C for 45 s, and a final
extension at 72°C for 10 min; 10 µg of the PCR
product was separated, run on a 1.5% agarose gel
and stained with ethidium bromide [10].
C Cy yt to ot to ox xi ic ci it ty y   a as ss sa ay y
The BMSCs were incubated with β-mercapto  -
ethanol, all-trans-retinoic acid and inducer medium
respectively. Prior to measuring viability, treatment
media  were  removed  and  replaced  with  100  µl 
fresh  10%  FBS/DMEM  medium  and  100  µl 
3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT) (Sigma, USA). Cells were then returned
to the incubator for an additional 4 h before 50 µl of
10% SDS was added to stop the reaction. Optical
density (OD) at 570 nm was read on a microplate
reader to indirectly reflect the number of viable cells.
The inhibition rate (IR, IR = [1-ODtest/ODcontrol] 
× 100) was used to evaluate the cytotoxicity of pre-
inducer and inducer media [20].
A An nn ne ex xi in n   V V/ /P PI I   a as ss sa ay ys s
To  confirm  apoptosis  induction,  annexin  V, 
and propidium iodide (PI) double staining was
performed by using the Annexin V-FITC Apoptosis
Detection Kit as described by the manufacturer
(Cat. No. 556420; BD Biosciences Pharmingen, San
Jose, CA). The cells stained with annexin V-FITC were
analysed with a flow cytometer (FACScan; Becton
Dickinson, Mountain View, CA) using Cell Quest
Software (BD Biosciences), which was also used to
determine the percentage of apoptotic and/or
necrotic cells [21].
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
The data were analysed with one-way ANOVA
and Tukey's test.
Results
R Ra at t   B BM MS SC Cs s   c ch ha ar ra ac ct te er ri iz za at ti io on n
The BMSCs appeared as a monolayer of large,
fibroblast-like flattened cells (Figure 1. A) which
when treated with appropriate induction media
G Ge en ne e P Pr ri im me er rs s
P75 Forward 5'-CATCTCTGTGGACAGCCAGA-3'
Reverse 5'-CTCTACCTCCTCACGCTTGG-3'
S100 Forward 5'-ATAGCACCTCCGTTGGACAG-3'
Reverse 5'-TCGTTTGCACAGAGGACAAG-3'
GFAP Forward 5'-GGTGTGGAGTGCCTTCGTAT-3' 
Reverse 5'-TACGATGTCCTGGGAAAAGG-3'
Beta actin Forward 5'-CTGGCACCCAGCACAATG-3'
Reverse 5'-AGCGAGGCCAGGATGGA-3'
T Ta ab bl le e   I I. . Primer sequences used for RT-PCR
F Fi ig gu ur re e   1 1. .   Undifferentiated BMSCs, under phase contrast microscopy, display a flattened fibroblast-like morphology (A A).
Alizarin Red staining of mineralised bone tissue (B B) and Oil Red O positive intracellular lipid droplets (C C) indicate
that these cells can differentiate to osteoblasts and adipocytes at ADSC 48 Arch Med Sci 1, February / 2011
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where able to adopt an osteogenic (Figure 1. B) or
adipogenic (Figure 1. C) phenotype.
Flow cytometry analysis of rat BMSCs within 
3-5 passages showed that rat BMSCs were CD90
and CD44 positive, but CD31 and CD45 negative
(Figure 2). 
I Im mm mu un no oc cy yt to oc ch he em mi is st tr ry y   o of f   B BM MS SC Cs s   a af ft te er r
i in nd du uc ct ti io on n
We detected the expression of SC marker 
S-100 to evaluate the nature of SC-like cells.
Almost all the differentiated BMSCs and Schwann
cells were also positive to the S-100 antibody
(Figure 3). After 14 days of induction, expression
of  S-100  protein  was  demonstrated  in  the
cytoplasm of SC-like cells.
R RT T- -P PC CR R   r re es su ul lt ts s
The  presence  of  the  glial  cell  marker  gene
transcripts was detected by RT-PCR methodology
(Figure 4). Before differentiation induction, BMSCs
were shown to be negative for S100, P75 and GFAP .
After 14 days of induction, BMSCs expressed the
transcripts for S100, P75 and GFAP compared to 
the  undifferentiated  BMSCs.  The  intensity  of 
S100 expression was higher than that of GFAP 
and similar to the Schwann cell group. RT-PCR
amplification efficacy of the mRNA was confir  -
med by amplification of the constitutively expres  -
sed beta actin housekeeping gene (Figure 4).
C Cy yt to ot to ox xi ic ci it ty y   a as ss sa ay y   
To study the cytotoxicity effect of BME, RA and
inducer medium on BMSCs during differentiation
into Schwann-like cells, we evaluated the viability
of BMSCs by MTT assay. This assay usually shows
high correlation with the number of living cells, cell
proliferation and release of mitochondrial matrix
enzymes.  The  BME,  RA  and  inducer  medium
significantly reduced BMSCs viability as assessed
by MTT assay (Figure 5).
Q Qu ua an nt ti if fi ic ca at ti io on n   o of f   a ap po op pt to os si is s   b by y   f fl lo ow w   c cy yt to om me et tr ry y
By staining cells with annexin V-FITC and PI,
FACS was used to distinguish and quantitatively
determine the percentage of viable cells (lower
F Fi ig gu ur re e   2 2. .   Flow cytometric analysis of rat BMSCs. Rat BMSCs within 3-5 passages were harvested and specific cell
surface antigens were detected. Cells stained with FITC-conjugated non-specific IgG were examined as a control
(FITC). Flow cytometric analysis shows that rat BMSCs do not express CD31 and CD45, but express CD90 and CD44
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left  quadrant),  apoptotic  cells  (lower  right
quadrant), late apoptotic necrotic cells (upper
right quadrant) and necrotic cells (upper left
quadrant)  after  sequential  administration  of 
β-mercaptoethanol, all-trans-retinoic acid and
a mixture of FSK, bFGF, PDGF and HRG was used
to induce differentiation of BMSCs into Schwann-
like cells (Figure 6. A). The proportions of viable
cells, early apoptotic cells, late apoptotic/necrotic
and necrotic cells for the control group were
94.34%, 2.34%, 1.62% and 1.7% respectively. For
cells  treated  with  β-merca  ptoethanol,  the
proportions were 78%, 14%, 6% and 2% respec  -
tively. For cells treated with all-trans-retinoic acid,
the proportions were 75.84%, 19.31%, 3.53% and
1.32% respectively. For cells treated with inducer
medium proportions were 80.84%, 13.93%, 5%
and 0.23% (Figure 6. B).
Discussion
Over the past decade, stem cells from adult bone
marrow have been exploited as therapeutic vectors
in the treatment of a wide variety of diseases [4, 5].
This study clearly shows the plasticity of BMSCs 
by their differentiation into Schwann-like cells 
F Fi ig gu ur re e   3 3. .   Immunocytochemistry of S100 in differentiated BMSCs (A A- -C C) and rat Schwann cell-line (D D- -F F). After the
induction, differentiated BMSCs became positive for S100 antibody. Rat Schwann cell-line was used as a positive
control. DAPI staining (A A, D D); S100 antibody (B B, E E); merge (C C, F F)50 Arch Med Sci 1, February / 2011
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with  the  typical  spindle-shaped  Schwann  cell
morphology. In this study we have confirmed that
the BMSCs express characteristic mesenchymal
stem cell (MSC) surface markers (CD44 and CD90
positive, but CD31 and CD45 negative) and also
demonstrated the multilineage potential of BMSCs
[13]. Clear evidence is provided to show that rat
BMSCs have the ability to differentiate along a glial
lineage and express cell markers (S100, P75 and
GFAP) which are typical for glial cells including
Schwann cells [3-8].
On the basis of our results, the sequential
administration of various factors, BME, RA, followed
by  a mixture  of  FSK,  bFGF,  PDGF  and  HRG,
effectively induces the differentiation of BMSCs into
Schwann-like cells. The phenotype of the differen  -
tiated BMSCs resembled that of Schwann cells. 
The previous reports showed that the addition of
BME to cultured BMSCs induced the formation of
neurite-like processes [14]. RA is a morphogenic
factor, and was reported to induce differentiation
of neural stem cells into nerve cells [15]. Therefore,
BME and RA are presumed to work as triggering
factors, inducing changes in the morphological and
transcriptional characteristics of BMSCs.
Previous studies reported that bFGF functions as
a mitogen for BMSCs, and that MAP kinases are
activated by PDGF and bFGF in MSCs [16]. HRG,
a subtype of neuregulin, instructively influences the
decision of cell fates and was reported to induce
neural  crest  cells  to  develop  selectively  into
Schwann cells [17].
FSK increases the level of intracellular cyclic
adenosine monophosphate (cAMP), which increases
mitogenic responses at an early time [18]. As cAMP
elevation is reported to enhance the responsiveness
of cells to trophic factors [19], FSK together with
bFGF, PDGF, and HRG could have a synergistic effect
in enhancement of these factors to BMSCs [20]. 
MTT assay and flow cytometry analysis for
annexin V and PI indicated that during the chemical
induction process there was an increase in cell
death. Putative early apoptotic cells increased after
exposure to BME and RA.
Measures  of  cell  death  during  this  specific
induction process are indicative of toxicity of the
chemical compounds used. Here we show that
almost 50% of cells die within 48 h of chemical
induction, in agreement with other studies [8, 10, 21].
Our results indicate that RA exerts two apparently
opposite effects on cultured ADSCs, i.e., a differen  -
tiating  effect  and  induction  of  cell  death.  Flow
cytometry analysis for annexin V and PI indicated 
that putative early apoptotic cells increased after
exposure to RA. These data agreed with previous
reports where all-trans-retinoic acid produced similar
effects in cancers [22] and stroke [23]. 
The  mechanism  of  the  apoptotic  effects  of 
β-mercaptoethanol and all-trans-retinoic acid is
unknown and there are several pathways that need
to be investigated. 
Oliva et al.  reported that antiproliferative activity
of retinoic acid is associated with (and probably 
due  to)  the  up-regulation  of  two  pivotal  cdk
inhibitors, and subsequent cdk2 activity decrease
and retinoblastoma protein (pRb) hypophospho  -
rylation [24].
pRb is a tumour suppressor protein that is
dysfunctional in many types of cancer [25]. In the
hypophosphorylated state, pRb is active and carries
out its role as a tumour suppressor by inhibiting
cell cycle progression [26].
However, there is evidence indicating that either
direct  contact  with  axons  or  survival  factors
secreted by neurons are necessary for the survival
F Fi ig gu ur re e   4 4. .   Transdifferentiated BMSCs were assayed
by  RT-PCR  for  S-100,  P75  and  GFAP  mRNA.
Undifferentiated  BMSCs  (a),  transdifferentiated
BMSCs (b) and rat Schwann cell-line was used as
a positive control (c)
F Fi ig gu ur re e    5 5. .    Histogram  shows  the  cytotoxicity  of 
β-mercaptoethanol,  all-trans-retinoic  acid  and
inducer medium on BMSCs identified by MTT assay.
C, B, R and D are non-treated cells (control), pre-
induced by β-mercaptoethanol, pre-induced by all-
trans-retinoic acid and induced by differentiated
medium respectively
a – significant difference with control group, b – significant
difference with β-mercaptoethanol group, c – significant
difference with all-trans-retinoic acid group, d – significant
difference with induction medium group (P < 0.05)
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and development of SC precursors as well as of
mature Schwann cell [8].
In conclusion, these findings indicated that
BMSCs could differentiate into Schwann-like cells
in terms of morphology and phenotype. As a side
effect of differentiation an increased cell death rate
was  noted  and  our  findings  indicate  that  the
principle mode of cell death is by apoptosis.
Hence, a considerable amount of BMSCs would
die during differentiation into Schwann-like cells,
depending  on  the  method  used.  This  may
compromise  the  optimal  outcome  of  the
engraftment and subsequently nerve regeneration
and repair.
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